Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial

por Upton, Caryn M., van Wijk, Rob C., Mockeliunas, Laurynas, Simonsson, Ulrika S.H., McHarry, Kirsten, van den Hoogen, Gerben, Muller, Chantal, von Delft, Arné, van der Westhuizen, Helene-Mari, van Crevel, Reinout, Walzl, Gerhard, Baptista, Pedro M., Peter, Jonathan, Diacon, Andreas H.
Publicado 2022

DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

por Madurka, Ildiko, Vishnevsky, Alexander, Soriano, Joan B., Gans, Stephanus J., Ore, Danilo Joel Salazar, Rendon, Adrian, Ulrik, Charlotte S., Bhatnagar, Sushma, Krishnamurthy, Srikanth, Mc Harry, Kirsten, Welte, Tobias, Fernandez, Alberto A., Mehes, Beata, Meiser, Karin, Gatlik, Ewa, Sommer, Ulrike, Junge, Guido, Rezende, Ederlon
Publicado 2022